Their medications are compounded, not FDA-approved, which is standard for this category of provider
For researchers studying hair biology through complementary mechanisms, TB-500 promotes hair follicle regeneration through stem cell mobilization a mechanism that complements GHK-Cus gene expression-based approach
First, phase II clinical trials evaluating MOTS-c in type 2 diabetes and sarcopenia are in development, and their results will provide the first randomized controlled evidence in humans to define therapeutic doses with statistical rigor
Never adjust your dose without consulting your prescriber
Subjective improvement in pain, function, and activity tolerance provides the primary effectiveness signal
However, it is important to discuss any new or persistent side effects with your healthcare professional so they can assess whether further review or changes to your treatment are needed